Isabel Fox
Founding Partner @ Luminous Ventures
London, United Kingdom
Isabel Fox is a seed investor at Luminous Ventures in London focused on Software and Life Science. Isabel Fox is based out of London, England, and is the Head of IR of Hoxton Ventures. Isabel previously worked at Molten Ventures as a Head Third Party Funds. Isabel Fox attended the University of Exeter. Isabel Fox has been certified as a Integrative Nutrition Health Coach (INHC).
- Total investments:
- 6
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Isabel Fox invests in
Stages Isabel Fox invests in
Countries Isabel Fox invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Software 2 (33%)
- Life Science 2 (33%)
- Biotechnology 2 (33%)
- Legal 1 (17%)
- Advice 1 (17%)
Stage
- Seed 1 (17%)
- Pre-Seed 1 (17%)
- Series A 1 (17%)
- Series B 1 (17%)
- Convertible Note 1 (17%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Treos Bio, Inc. is a computational immunology and immunotherapy company which has developed a proprietary technology to predict in silico likely responders to cancer immunotherapies and to design in silico next generation targeted immunotherapies for a large population of cancer patients. | $16.4M / Convertible Note / Mar 31, 2021 | ||
| Synthace is a digital experiment platform built for life science R&D teams to help them run more powerful experiments. It digitizes experiments from end to end: with minimal training, scientists can design and plan reproducible experiments, simulate them ahead of time, run them on their automation equipment, and automatically structure all oftheir experimental data and metadata in a single place. Controlled from a browser window and needing no code to operate, it makes experiments easier to run in the lab, increases the scientific value of experiments, and also makes it possible to run experiments that were previously thought impossible. | $25.6M / Series B / Dec 12, 2018 | ||
| Your knowledgeable companion for everything after life. Whatever journey you’re on, you can trust Beyond to help you make the best decision. | $2.8M / Seed / Feb 15, 2018 | ||
| Synthace is a digital experiment platform built for life science R&D teams to help them run more powerful experiments. It digitizes experiments from end to end: with minimal training, scientists can design and plan reproducible experiments, simulate them ahead of time, run them on their automation equipment, and automatically structure all oftheir experimental data and metadata in a single place. Controlled from a browser window and needing no code to operate, it makes experiments easier to run in the lab, increases the scientific value of experiments, and also makes it possible to run experiments that were previously thought impossible. | $9.9M / Series A / Sep 19, 2017 | ||
| Sparrho is a world leader in making science accessible to build trust in brands. They achieve this using their unique combination of AI and PhD experts, which they call Augmented Intelligence.Sparrho was founded in 2013 out of frustration with existing literature search tools by two Oxbridge scientists, and now has a growing and tightly knit teambased in London, UK.Today Sparrho caters to Fortune 500 companies across the globe. Their platform uses augmented intelligence to aggregate, curate and summarise the latest in scientific research. | $3M / Venture - Series Unknown / Jul 10, 2017 | ||
| Your knowledgeable companion for everything after life. Whatever journey you’re on, you can trust Beyond to help you make the best decision. | $919.7K / Pre-Seed / Oct 11, 2016 |
Co-Investors
About Luminous Ventures
Luminous Ventures is a London-based VC fund investing in Deep Tech with a focus on the application of innovative technologies to healthcare, life science, nutrition, food and agriculture. Investing at Seed and Series A, Luminous has backed companies in Europe and North America.
Luminous Ventures Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alasdair Thong
Venture Partner
|
|||
Lomax Ward
Founding Partner
|
|||
|
Miao He
Associate
|
|||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Isabel Fox invest in?
Isabel Fox invests primarily in Software, Life Science and Biotechnology startups, most often at Seed and Pre-Seed stage. Most of the 6 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Isabel Fox?
Public channels for Isabel Fox include LinkedIn, X (Twitter) and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Isabel Fox last invest?
The most recent investment recorded for Isabel Fox closed in Mar 2021. Shizune tracks 6 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
